Marshall Wace
BLU

Marshall Wace’s BELLUS Health Inc. BLU Stock Holding History

Marshall Wace’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,520,633
Closed -$10.9M – 3164
2023
Q1 		$10.9M Sell
1,520,633
-61,532
-4% -$477K 0.02% 680
2022
Q4 		$13M Sell
1,582,165
-76,817
-5% -$716K 0.03% 670
2022
Q3 		$17.5M Buy
1,658,982
+896,878
+118% +$9.53M 0.04% 524
2022
Q2 		$7.04M Buy
+762,104
New +$6.23M 0.01% 1114

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Marshall Wace's BLU Position: Q2 2023 in Review

Marshall Wace sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 1,520,633 shares — an estimated $10.9M sold.

Marshall Wace first reported a position in BLU in Q2 2022 and held it in 4 quarters. The position peaked at $17.5M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Marshall Wace reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Marshall Wace sold 1,520,633 BELLUS Health Inc. shares in Q2 2023, an estimated $10.9M.
  • Marshall Wace first reported a position in BELLUS Health Inc. in Q2 2022 and held it in 4 quarters.
  • Marshall Wace's BELLUS Health Inc. position peaked at $17.5M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.